Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Retatrutide 20mg formally designated LY-3437943 is Eli Lillys investigational synthetic triple-receptor agonist peptide that simultaneously activates three key hormone pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor (GCGR)
BMJ 380 , e072705 (2023)
Cytokines, chemokines and growth factors in wound healing
This approach supports individualized care while maintaining consistency across treatment phases
The global GLP-1 market is forecast to reach approximately $58 billion in 2026, driven by soaring demand for obesity and diabetes treatments
US$ 21.71
US$ 25.20
US$ 24.58
US$ 24.11
US$ 23.56
